RESUMEN
This study evaluated the anesthetic and cardiorespiratory effects of a combination of intravenous propofol (2.2 mg/kg), intramuscular medetomidine (22.0 pg/kg), intravenous butorphanol (0.22 mg/kg), and intravenous atropine (0.022 mg/kg) in healthy dogs. Anesthesia was characterized by muscle relaxation and analgesia. Heart rate decreased after medetomidine and propofol administration (131 to 113 beats/min) but returned to baseline after intravenous atipamezole (110 microg/kg). Mild acidemia, hypercapnia, hypoxemia, and decreased SaO2 developed after premedication. PaO2 and SaO2 were further decreased by propofol injection. In conclusion, this combination proved to be an effective anesthetic protocol for healthy dogs and should be adequate for minor surgical procedures.
Asunto(s)
Anestesia General/veterinaria , Atropina/farmacología , Butorfanol/farmacología , Medetomidina/farmacología , Propofol/farmacología , Adyuvantes Anestésicos/administración & dosificación , Adyuvantes Anestésicos/farmacología , Analgésicos no Narcóticos/administración & dosificación , Analgésicos no Narcóticos/farmacología , Analgésicos Opioides/administración & dosificación , Analgésicos Opioides/farmacología , Anestésicos Intravenosos/administración & dosificación , Anestésicos Intravenosos/farmacología , Animales , Atropina/administración & dosificación , Presión Sanguínea/efectos de los fármacos , Butorfanol/administración & dosificación , Perros , Femenino , Masculino , Medetomidina/administración & dosificación , Propofol/administración & dosificación , Factores de TiempoRESUMEN
OBJECTIVE: To determine the effect of medetomidine on the stress response induced by ovariohysterectomy in isoflurane-anesthetized dogs. STUDY DESIGN: Prospective randomized study. ANIMALS: Twelve healthy adult female purpose-bred dogs, weighing 16.8 to 25 kg. METHODS: Two treatments were randomly administered to each of twelve dogs at weekly intervals: (1) Saline injected IM followed in 15 minutes by isoflurane anesthesia (ISO) induced by mask and maintained at an end-tidal concentration of 1.8% for 60 minutes; and (2) Medetomidine, 15 ug/lkg IM followed in 15 minutes by isoflurane anesthesia (ISO&MED) induced by mask and maintained at an end-tidal concentration of 1.0% for 60 minutes. One week after completion of these two treatments, all dogs were ovariohysterectomized. six receiving each treatment (SURG and SURG&MED). Central venous blood samples (10 mL) were obtained immediately before medetomidine or saline (baseline) and at 30, 75, and 195 minutes and 24 hours after administration of medetomidine or saline in ISO and ISO&MED. In SURG and SURG&MED, samples were obtained immediately prior to injection of medetomidine or saline (baseline) and at 30 (before skin incision), 45 (after severence of the ovarian ligament), 75 (after skin closure), 105 (30 minutes after skin closure, dog recovered and in sternal recumbency), 135, 195, 375 minutes, and 24 hours after the initial sample. Samples were analyzed for epinephrine, norepinephrine, adrenocorticotrophic hormone (ACTH), cortisol, insulin, and glucose. Data were analyzed by analysis of variance and where significant differences were found, a least significant difference test was applied. RESULTS: Premedication with medetomidine prevented or delayed the stress response induced by ovariohysterectomy in isoflurane-anesthetized dogs. CONCLUSIONS: The stress response induced by ovariohysterectomy, although significant, is of short duration. Medetomidine safely and effectively reduced surgically-induced stress responses. CLINICAL RELEVANCE: Surgically induced stress responses can be obtunded or prevented by administration of medetomidine.
Asunto(s)
Enfermedades de los Perros/prevención & control , Hipnóticos y Sedantes/administración & dosificación , Medetomidina/administración & dosificación , Estrés Fisiológico/veterinaria , Adaptación Fisiológica/efectos de los fármacos , Hormona Adrenocorticotrópica/sangre , Anestésicos por Inhalación , Animales , Glucemia/análisis , Enfermedades de los Perros/sangre , Enfermedades de los Perros/cirugía , Perros , Epinefrina/sangre , Femenino , Hidrocortisona/sangre , Histerectomía/efectos adversos , Histerectomía/veterinaria , Inyecciones Intramusculares/veterinaria , Insulina/sangre , Isoflurano , Norepinefrina/sangre , Ovariectomía/efectos adversos , Ovariectomía/veterinaria , Premedicación/veterinaria , Estudios Prospectivos , Estrés Fisiológico/sangre , Estrés Fisiológico/prevención & controlRESUMEN
OBJECTIVE: To assess duration of actions of butorphanol, medetomidine, and a butorphanol-medetomidine combination in dogs given subanesthetic doses of isoflurane (ISO). ANIMALS: 6 healthy dogs. PROCEDURE: Minimum alveolar concentration (MAC) values for ISO were determined. for each dog. Subsequently, 4 treatments were administered to each dog (saline [0.9% NaCl] solution, butorphanol [0.2 mg/kg of body weight], medetomidine [5.0 microg/kg], and a combination of butorphanol [0.2 mg/kg] and medetomidine [5.0 microg/kg]). All treatments were administered IM to dogs concurrent with isoflurane; treatment order was determined, using a randomized crossover design. Treatments were given at 7-day intervals. After mask induction with ISO and instrumentation with a rectal temperature probe, end-tidal CO2 and anesthetic gas concentrations were analyzed. End-tidal ISO concentration was reduced to 90% MAC for each dog. A tail clamp was applied 15 minutes later. After a positive response, 1 of the treatments was administered. Response to application of the tail clamp was assessed at 15-minute intervals until a positive response again was detected. RESULTS: Duration of nonresponse after administration of saline solution, butorphanol, medetomidine, and butorphanol-medetomidine (mean +/- SD) was 0.0+/-0.0, 1.5+/-1.5, 2.63+/-0.49, and 5.58+/-2.28 hours, respectively. Medetomidine effects were evident significantly longer than those for saline solution, whereas effects for butorphanol-medetomidine were evident significantly longer than for each agent administered alone. CONCLUSION AND CLINICAL RELEVANCE: During ISO-induced anesthesia, administration of medetomidine, but not butorphanol, provides longer and more consistent analgesia than does saline solution, and the combination of butorphanol-medetomidine appears superior to the use of medetomidine or butorphanol alone.
Asunto(s)
Analgésicos no Narcóticos , Analgésicos Opioides , Anestésicos Combinados , Butorfanol , Perros/fisiología , Medetomidina , Analgésicos no Narcóticos/administración & dosificación , Analgésicos Opioides/administración & dosificación , Anestésicos Combinados/administración & dosificación , Anestésicos por Inhalación , Animales , Temperatura Corporal , Butorfanol/administración & dosificación , Estudios Cruzados , Inyecciones Intramusculares/veterinaria , Isoflurano , Máscaras Laríngeas , Medetomidina/administración & dosificación , Distribución Aleatoria , Cola (estructura animal)RESUMEN
OBJECTIVES: To evaluate the effects of halothane and isoflurane on cardiovascular function and serum total and ionized calcium concentrations in horses, and to determine whether administration of calcium gluconate would attenuate these effects. ANIMALS: 6 clinically normal adult Thoroughbreds. PROCEDURE: Catheters were inserted for measurement of arterial blood pressures, pulmonary arterial blood pressures, right ventricular pressure (for determination of myocardial contractility), right atrial pressure, and cardiac output and for collection of arterial blood samples. Anesthesia was then induced with xylazine hydrochloride and ketamine hydrochloride and maintained with halothane or isoflurane. An i.v. infusion of calcium gluconate was begun 75 minutes after anesthetic induction; dosage of calcium gluconate was 0.1 mg/kg of body weight/min for the first 15 minutes, 0.2 mg/kg/min for the next 15 minutes, and 0.4 mg/kg/min for an additional 15 minutes. Data were collected before, during, and after administration of calcium gluconate. RESULTS: Halothane and isoflurane decreased myocardial contractility, cardiac index, and mean arterial pressure, but halothane caused greater depression than isoflurane. Calcium gluconate attenuated the anesthetic-induced depression in cardiac index, stroke index, and maximal rate of increase in right ventricular pressure when horses were anesthetized with isoflurane. When horses were anesthetized with halothane, a higher dosage of calcium gluconate was required to attenuate the depression in stroke index and maximal rate of increase in right ventricular pressure; cardiac index was not changed with calcium administration. CONCLUSIONS AND CLINICAL RELEVANCE: I.v. administration of calcium gluconate may support myocardial function in horses anesthetized with isoflurane.
Asunto(s)
Calcio/sangre , Halotano/farmacología , Hemodinámica/efectos de los fármacos , Caballos/fisiología , Isoflurano/farmacología , Anestesia por Inhalación/veterinaria , Animales , Presión Sanguínea/efectos de los fármacos , Gasto Cardíaco/efectos de los fármacos , Femenino , Hemodinámica/fisiología , Masculino , Orquiectomía , Arteria Pulmonar/efectos de los fármacos , Volumen Sistólico/efectos de los fármacos , Factores de TiempoRESUMEN
OBJECTIVES: To determine the most repeatable method for evaluating right ventricular relaxation rate in horses and to determine and compare effects of isoflurane or halothane with and without the added influence of intravenously administered calcium gluconate on right ventricular relaxation rates in horses. ANIMALS: 6 Thoroughbred horses from 2 to 4 years old. PROCEDURE: 6 models (2 for monoexponential decay with zero asymptote, 3 for monoexponential decay with variable asymptote, and 1 for biexponential decay) for determining right ventricular relaxation rate were assessed in conscious and anesthetized horses. The 2 methods yielding the most repeatable results then were used to determine right ventricular relaxation rates in horses anesthetized with isoflurane or halothane before, during, and after i.v. administration of calcium gluconate. Right ventricular pressure was measured, using a catheter-tip high-fidelity pressure transducer, and results were digitized at 500 Hz from minimum rate of change in ventricular pressure. RESULTS: 2 models that used monoexponential decay with zero asymptote repeatedly produced an estimate for relaxation rate and were used to analyze effects of anesthesia and calcium gluconate administration on relaxation rate. Isoflurane and halothane each prolonged right ventricular relaxation rate, with greater prolongation evident in halothane-anesthetized horses. Calcium gluconate attenuated the anesthesia-induced prolongation in right ventricular relaxation rate, with greater response obtained in isoflurane-anesthetized horses. CONCLUSIONS AND CLINICAL RELEVANCE: Right ventricular relaxation rate in horses is assessed best by use of a monoexponential decay model with zero asymptote and nonlinear regression. Intravenous administration of calcium gluconate to isoflurane-anesthetized horses best preserves myocardial relaxant function.
Asunto(s)
Anestésicos por Inhalación/uso terapéutico , Pruebas de Función Cardíaca/veterinaria , Ventrículos Cardíacos/fisiopatología , Enfermedades de los Caballos/fisiopatología , Modelos Biológicos , Animales , Gluconato de Calcio/uso terapéutico , Femenino , Halotano/uso terapéutico , Enfermedades de los Caballos/diagnóstico , Caballos , Inyecciones Intravenosas/veterinaria , Isoflurano/uso terapéutico , Masculino , Análisis de Regresión , Reproducibilidad de los Resultados , Xilazina/uso terapéuticoRESUMEN
OBJECTIVE: To determine effectiveness of rapid i.v. administration of hypertonic saline-dextran (HSD) solution combined with oral administration of isotonic electrolyte solution for resuscitating severely dehydrated calves and to compare the resuscitative response with that of a conventional treatment of lactated Ringer's solution (LRS) i.v. and orally administered isotonic electrolyte solution. DESIGN: Prospective study. ANIMALS: 15 male dairy calves 3 to 10 days old. PROCEDURE: Baseline data were obtained. Osmotic diarrhea and severe dehydration were induced for 48 hours. Calves were then allocated to 3 treatment groups. The control group (group C) did not receive fluids, a second group (group H) received hypertonic saline (7.2% NaCl) solution with 6% dextran 70 and isotonic electrolyte solution, and a third group (group L) received LRS and isotonic electrolyte solution. Physical examinations were performed every 8 hours. RESULTS: Calves developed diarrhea, lethargy, severe dehydration (mean, 14% of body weight), azotemia, hyperkalemia, and mild acidemia. Group-C calves remained lethargic and severely dehydrated during the 24-hour treatment phase. Calves treated with HSD and LRS were effectively resuscitated; however, response for most variables was more rapid and sustained for the HSD-treated group. Cardiac output was greater in LRS- than HSD-treated calves 1, 2, and 8 hours after initiation of treatment because of continued i.v. administration of fluids. CLINICAL IMPLICATIONS: A combination of HSD and isotonic electrolyte solution was a rapid and effective method for resuscitation of severely dehydrated calves. It was similar in effectiveness to conventional treatment in which LRS and isotonic electrolyte solution were used for resuscitating calves with severe dehydration.
Asunto(s)
Enfermedades de los Bovinos/terapia , Deshidratación/veterinaria , Diarrea/veterinaria , Fluidoterapia/veterinaria , Administración Oral , Animales , Animales Recién Nacidos , Gasto Cardíaco , Bovinos , Enfermedades de los Bovinos/fisiopatología , Deshidratación/etiología , Deshidratación/fisiopatología , Deshidratación/terapia , Dextranos/administración & dosificación , Diarrea/complicaciones , Diarrea/fisiopatología , Electrólitos/administración & dosificación , Infusiones Intravenosas/veterinaria , Soluciones Isotónicas/administración & dosificación , Masculino , Volumen Plasmático , Estudios Prospectivos , Distribución Aleatoria , Soluciones para Rehidratación/administración & dosificación , Lactato de Ringer , Solución Salina Hipertónica/administración & dosificación , Volumen Sistólico , MicciónRESUMEN
OBJECTIVE: To investigate the relation between cardiac output (CO) and peripheral (fetlock) temperature (PT) and core-peripheral (rectal-fetlock) temperature difference (CPTD) in dehydrated calves housed in a thermoneutral environment. ANIMALS: 28 male dairy calves 3 to 10 days old. PROCEDURE: Severe dehydration and watery diarrhea were induced by administering diuretics (furosemide, hydrohlorothiazide, spironolactone) and sucrose solution. Cardiac output was measured by means of thermodilution, core temperature was determined by placing a digital thermometer in the rectum, and PT was measured by taping a thermistor to the left hind fetlock and insulating the thermistor from ambient air. RESULTS: In thermoneutral ambient temperatures (10 to 24 C), PT and CPTD were constant and independent of CO at normal or high CO values but were linearly dependent on CO below a critical value (78% of normal CO output). Regression equations were developed that predicted CO from measured PT or CPTD. At ambient temperatures below the lower critical temperature for neonatal calves (8 to 10 C), normal values for PT and CPTD in healthy calves were significantly different from those at thermoneutral ambient temperatures. CONCLUSIONS AND CLINICAL RELEVANCE: Peripheral temperature and CPTD are practical, noninvasive, and inexpensive but only moderately useful methods for predicting CO in hemodynamically stable calves housed in a thermoneutral environment. Thus, these parameters are of some value in daily monitoring of the response to treatment and in determining need for i.v. fluid administration in dehydrated calves housed at a dry still-air temperature of 10 to 24 C but are of minimal to no value in calves housed at < 10 C.
Asunto(s)
Temperatura Corporal , Gasto Cardíaco , Enfermedades de los Bovinos/fisiopatología , Deshidratación/veterinaria , Diarrea/veterinaria , Hemodinámica , Animales , Animales Recién Nacidos , Presión Sanguínea , Bovinos , Deshidratación/inducido químicamente , Deshidratación/fisiopatología , Diarrea/inducido químicamente , Diarrea/fisiopatología , Diuréticos , Electrólitos/sangre , Furosemida , Frecuencia Cardíaca , Vivienda para Animales , Hidroclorotiazida , Masculino , Espironolactona , TemperaturaRESUMEN
Fifteen healthy, colostrum-fed, male dairy calves, aged 2 to 7 d were used in a study to develop a diarrhea protocol for neonatal calves that is reliable, practical, and economical. After instrumentation and recording baseline data, diarrhea and dehydration were induced by administering milk replacer [16.5 mL/kg of body weight (BW), PO], sucrose (2 g/kg in a 20% aqueous solution, p.o.), spironolactone and hydrochlorothiazide (1 mg/kg, PO) every 8 h, and furosemide (2 mg/kg, i.m., q6h). Calves were administered sucrose and diuretic agents for 48 h to induce diarrhea and severe dehydration. Clinical changes after 48 h were severe watery diarrhea, severe depression, and marked dehydration (mean, 14% BW loss). Cardiac output, stroke volume, mean central venous pressure, plasma volume, thiocyanate space, blood pH and bicarbonate concentration, base excess, serum chloride concentration, and fetlock temperature were decreased. Plasma lactate concentration, hematocrit, and serum potassium, creatinine, phosphorus, total protein and albumin concentrations were increased. This non-infectious calf diarrhea protocol has a 100% response rate, while providing a consistent and predictable hypovolemic state with diarrhea that reflects most of the clinicopathologic changes observed in osmotic/maldigestive diarrhea caused by infection with rotavirus, coronavirus or cryptosporidia. Limitations of the protocol, when compared to infectious diarrhea models, include failure to induce a severe metabolic acidosis, absence of hyponatremia, renal instead of enteric loss of chloride, renal as well as enteric loss of free water, absence of profound clinical depression and suspected differences in the morphologic and functional effect on intestinal epithelium. Despite these differences, the sucrose/diuretic protocol should be useful in the initial screening of new treatment modalities for calf diarrhea. To confirm their efficacy, the most effective treatment methods should then be examined in calves with naturally-acquired diarrhea.
Asunto(s)
Deshidratación/fisiopatología , Diarrea/fisiopatología , Hemodinámica , Animales , Animales Recién Nacidos , Glucemia/análisis , Proteínas Sanguíneas/análisis , Temperatura Corporal , Peso Corporal , Bovinos , Calostro , Deshidratación/sangre , Deshidratación/inducido químicamente , Diarrea/sangre , Diarrea/inducido químicamente , Electrólitos/sangre , Heces , Furosemida/administración & dosificación , Hidroclorotiazida/administración & dosificación , Masculino , Espironolactona/administración & dosificación , Sacarosa/administración & dosificaciónRESUMEN
This study evaluated the quality of anaesthesia and some of the haemodynamic effects induced by a combination of thiopental, medetomidine, butorphanol and atropine in healthy beagle dogs (n = 12). Following premedication with atropine (ATR, 0.022 mg/kg intravenously (i.v.)) and butorphanol (BUT, 0.22 mg/kg i.v.), medetomidine (MED, 22 micrograms/kg intramuscularly (i.m.)) was administered followed in 5 min by thiopental (THIO, 2.2 mg/kg i.v.). Heart rate, systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial blood pressure (MBP) were monitored continuously with an ECG and direct arterial blood pressure monitor. Atipamezole (ATI, 110 micrograms/kg i.v.) was administered to half of the dogs (n = 6) following surgery to evaluate the speed and quality of arousal from anaesthesia. Anaesthesia was characterized by excellent muscle relaxation, analgesia and absence of purposeful movement in response to surgical castration. Arousal following antagonism of medetomidine was significantly faster (P < 0.05) than in unantagonized dogs. Recoveries were smooth but recovery times following atipamezole administration were highly variable among dogs (sternal time range 6-38 min, standing time range 9-56 min). Medetomidine caused a significant (P < 0.05) increase in SBP, DBP and MBP. Atropine prevented the medetomidine induced bradycardia. In conclusion, this combination provided adequate surgical anaesthesia in healthy beagle dogs. At the dosages used in this study, it seems prudent that this combination should be reserved for dogs free of myocardial disease.
Asunto(s)
Anestesia , Butorfanol/farmacología , Perros , Hipnóticos y Sedantes/farmacología , Imidazoles/farmacología , Tiopental/farmacología , Adyuvantes Anestésicos/administración & dosificación , Adyuvantes Anestésicos/farmacología , Animales , Nivel de Alerta/efectos de los fármacos , Atropina/metabolismo , Atropina/farmacología , Presión Sanguínea/efectos de los fármacos , Butorfanol/metabolismo , Interacciones Farmacológicas , Frecuencia Cardíaca/efectos de los fármacos , Hipnóticos y Sedantes/administración & dosificación , Imidazoles/administración & dosificación , Inyecciones Intramusculares/veterinaria , Inyecciones Intravenosas/veterinaria , Medetomidina , Tiopental/administración & dosificaciónRESUMEN
OBJECTIVE: The purpose of this study was to determine the hemodynamic effects of epidural ketamine administered during isoflurane anesthesia in dogs. STUDY DESIGN: Prospective, single-dose trial. ANIMALS: Six healthy dogs (five males, one female) weighing 25.3 +/- 3.88 kg. METHODS: Once anesthesia was induced, dogs were maintained at 1.5 times the predetermined, individual minimum alveolar concentration (MAC) of isoflurane. Dogs were instrumented and allowed to stabilize for 30 minutes before baseline measurements were recorded. Injection of 2 mg/kg of ketamine in 1 mL saline/4.5 kg body weight was then performed at the lumbosacral epidural space. Hemodynamic data were recorded at 5, 10, 15, 20, 30, 45, 60, and 75 minutes after epidural ketamine injection. Statistical analysis included an analysis of variance (ANOVA) for repeated measures over time. All data were compared with baseline values. A P < .05 was considered significant. RESULTS: Baseline values +/- standard error of the mean (X +/- SEM) for heart rate, mean arterial pressure, mean pulmonary artery pressure, central venous pressure, pulmonary capillary wedge pressure, cardiac index, stroke index, systemic vascular resistance, pulmonary vascular resistance, and rate-pressure product were 108 +/- 6 beats/min, 85 +/- 10 mm Hg, 10 +/- 2 mm Hg, 3 +/- 1 mm Hg, 5 +/- 2 mm Hg, 2.3 +/- 0.3 L/min/m2, 21.4 +/- 1.9 mL/beat/m2, 3386 +/- 350 dynes/sec/cm5, 240 +/- 37 dynes/sec/cm5, and 12376 +/- 1988 beats/min x mm Hg. No significant differences were detected from baseline values at any time after ketamine injection. CONCLUSIONS: The epidural injection of 2 mg/kg of ketamine is associated with minimal hemodynamic effects during isoflurane anesthesia. CLINICAL RELEVANCE: These results suggest that if epidural ketamine is used for analgesia in dogs, it will induce minimal changes in cardiovascular function.
Asunto(s)
Anestesia Epidural/veterinaria , Anestésicos Combinados/farmacología , Anestésicos Disociativos/farmacología , Perros/fisiología , Hemodinámica/efectos de los fármacos , Ketamina/farmacología , Anestesia por Inhalación/veterinaria , Anestésicos Combinados/administración & dosificación , Anestésicos Disociativos/administración & dosificación , Anestésicos por Inhalación , Animales , Presión Sanguínea/efectos de los fármacos , Presión Sanguínea/fisiología , Fenómenos Fisiológicos Cardiovasculares/efectos de los fármacos , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Frecuencia Cardíaca/fisiología , Hemodinámica/fisiología , Inyecciones Epidurales/veterinaria , Isoflurano , Ketamina/administración & dosificación , Masculino , Estudios Prospectivos , Volumen Sistólico/efectos de los fármacos , Volumen Sistólico/fisiología , Resistencia Vascular/efectos de los fármacos , Resistencia Vascular/fisiologíaRESUMEN
Calcium gluconate was administered to conscious horses at 3 different rates (0.1, 0.2, and 0.4 mg/kg/min for 15 minutes each). Serum calcium concentrations and parameters of cardiovascular function were evaluated. All 3 calcium administration rates caused marked increases in both ionized and total calcium concentrations, cardiac index, stroke index, and cardiac contractility (dP/dtmax). Mean arterial pressure and right atrial pressure were unchanged; heart rate decreased markedly during calcium administration. Ionized calcium concentration remained between 54% and 57% of total calcium concentration throughout the study. We conclude that calcium gluconate can safely be administered to conscious horses at 0.1 to 0.4 mg/kg/min and that administration will result in improved cardiac function.
Asunto(s)
Gluconato de Calcio/farmacología , Estado de Conciencia/fisiología , Hemodinámica/efectos de los fármacos , Caballos/fisiología , Animales , Presión Sanguínea/efectos de los fármacos , Presión Sanguínea/fisiología , Calcio/sangre , Gluconato de Calcio/administración & dosificación , Gasto Cardíaco/efectos de los fármacos , Gasto Cardíaco/fisiología , Relación Dosis-Respuesta a Droga , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Frecuencia Cardíaca/fisiología , Hemodinámica/fisiología , Caballos/sangre , Infusiones Intravenosas , Masculino , Contracción Miocárdica/efectos de los fármacos , Contracción Miocárdica/fisiología , Respiración/efectos de los fármacos , Respiración/fisiología , Volumen Sistólico/efectos de los fármacos , Volumen Sistólico/fisiología , Factores de TiempoRESUMEN
OBJECTIVE: To evaluate the ability of flumazenil (FLU), butorphanol (BUT), and naloxone (NAL) to reverse the anesthetic effects of oxymorphone-diazepam in dogs. ANIMALS: 6 healthy adult mixed-bread dogs. PROCEDURE: Dogs were randomly assigned to each of 6 reversal treatment groups. In each experiment, oxymorphone (0.22 mg/kg of body weight, i.v.) and diazepam (0.22 mg/kg. i.v.) were given sequentially 15 minutes after glycopyrrolate (0.01 mg/kg, i.v.) administration. Physiologic saline solution (SAL; 1 ml), FLU (0.01 mg/kg), BUT (0.44 mg/kg), or NAL (0.06 mg/kg) alone, or FLU-BUT or FLU-NAL (same dosages) was given i.v. as a reversal treatment 15 minutes after oxymorphone-diazepam administration. An individual unaware of the treatment protocol recorded time to extubation, sternal recumbency, and walking. RESULTS: Time to extubation was significantly (P < 0.05) less with BUT, NAL, FLU-BUT, or FLU-NAL treatment, compared with that for SAL treatment. Time to sternal recumbency was less with BUT, NAL, FLU-BUT, or FLU-NAL treatment, compared with that for SAL treatment. Time to walking was less with FLU-BUT or FLU-NAL treatment, compared with that for SAL treatment. CLINICAL IMPLICATIONS: Flumazenil, in combination with BUT or NAL, can be used to reverse the anesthetic effects of oxymorphone-diazepam in dogs.
Asunto(s)
Anestésicos Combinados , Butorfanol/farmacología , Perros/fisiología , Flumazenil/farmacología , Naloxona/farmacología , Antagonistas de Narcóticos/farmacología , Adyuvantes Anestésicos , Animales , Estudios Cruzados , Diazepam , Combinación de Medicamentos , Femenino , Masculino , Oximorfona , Factores de TiempoAsunto(s)
Arritmias Cardíacas/veterinaria , Enfermedades de los Bovinos/fisiopatología , Electrocardiografía/veterinaria , Anestésicos por Inhalación/efectos adversos , Animales , Arritmias Cardíacas/inducido químicamente , Arritmias Cardíacas/fisiopatología , Bovinos , Enfermedades de los Bovinos/inducido químicamente , Femenino , Halotano/efectos adversosRESUMEN
OBJECTIVE: To determine effectiveness of a new and practical method for fluid resuscitation of dehydrated diarrheic calves. DESIGN: Animals randomly allocated to 4 groups with appropriate controls. ANIMALS: 16 healthy male dairy calves, 3 to 6 days old. PROCEDURE: After instrumentation and recording baseline data, diarrhea and hypovolemia were induced by administering milk replacer (33 ml/kg of body weight) and isotonic sucrose solution (2 g of sucrose in 19.5 ml of water/kg, PO) every 8 hours, and furosemide (2 mg/kg, IM) every 4 to 8 hours. Administration of milk replacer and furosemide was discontinued when calves became 6% dehydrated. Calves were then randomly allocated as: control (no treatment); hypertonic saline-dextran (HSD) solution (4 ml/kg, 2,400 mOsm/L NaCl in 6% dextran-70, administered once over 4 minutes, IV); isotonic alkalinizing oral electrolyte solution (55 ml/kg, PO, q 8 h); and HSD-oral electrolyte solution (combination of HSD and oral treatments). Calves were monitored for 24 hours after treatment. RESULTS: Significant changes included moderate dehydration (8% body weight), marked lethargy, decreased cardiac output and plasma volume, and increased blood lactate concentration, hematocrit, and serum concentrations of albumin, creatinine, sodium, and phosphate. Control calves continued to be lethargic and dehydrated, with significant increases in hematocrit and serum creatinine concentration. Increase in cardiac output and plasma volume was transient in the HSD group and waned by 2 to 8 hours after treatment. Oral electrolyte fluid administration caused slow and sustained increase in cardiac output and plasma volume, and decrease in heart rate, blood lactate concentration, and hematocrit. Combined administration of HSD-oral electrolyte solution caused immediate and sustained increase in cardiac output and plasma volume, and decrease in heart rate, blood lactate concentration, and hematocrit. CONCLUSIONS AND CLINICAL RELEVANCE: Treatment of hypovolemic diarrheic calves with IV HSD and oral electrolyte solution is superior to administration of either solution alone.
Asunto(s)
Enfermedades de los Bovinos , Dextranos , Diarrea/veterinaria , Soluciones Hipertónicas , Resucitación/veterinaria , Choque/veterinaria , Cloruro de Sodio , Animales , Animales Recién Nacidos , Volumen Sanguíneo , Peso Corporal , Gasto Cardíaco , Bovinos , Creatinina/sangre , Diarrea/fisiopatología , Hematócrito , Lactatos/sangre , Masculino , Fosfatos/sangre , Resucitación/métodos , Albúmina Sérica/análisis , Choque/fisiopatología , Choque/terapia , Sodio/sangre , Volumen SistólicoRESUMEN
The anaesthetic effects of intravenous tiletamine-zolazepam 6.6 mg/kg-ketamine 6.6 mg/kg (TK) and tiletamine-zolazepam 6.6 mg/kg-ketamine 6.6 mg/kg-xylazine 0.11 mg/kg (TKX) were evaluated in six wethers. Heart rate, respiration rate, arterial blood pressure, and the electrocardiogram were monitored during anaesthesia. Analgesia was tested by electrical stimulation in the left flank. Atropine (0.03 mg/kg) was given intramuscularly before induction, but after recording of baseline heart rate and respiratory rate. The duration of analgesia was 28.7 +/- 6.9 min with TK and 82.8 +/- 26.6 min with TKX. Heart rate increased significantly within 5 min after TK or TKX administration. Respiratory rate remained unchanged after TK administration, but increased significantly from 5 to 45 min after TKX administration. Arterial blood pressure decreased significantly at 15 min with TK and 30 min with TKX. Sheep remained recumbent for 201 min with TK and 166 min with TKX. All recovered uneventfully. We conclude that either TK or TKX may be used for anaesthetising sheep.
Asunto(s)
Anestesia Intravenosa/veterinaria , Anestésicos Intravenosos , Ovinos/fisiología , Animales , Presión Sanguínea/efectos de los fármacos , Estudios Cruzados , Combinación de Medicamentos , Frecuencia Cardíaca/efectos de los fármacos , Ketamina , Masculino , Relajación Muscular/efectos de los fármacos , Respiración/efectos de los fármacos , Tiletamina , Xilazina , ZolazepamRESUMEN
Hemodynamic and analgesic effects of medetomidine (15 micrograms/kg of body weight, IM) and etomidate (0.5 mg/kg, IV, loading dose; 50 micrograms/kg/min, constant infusion) were evaluated in 6 healthy adult Beagles. Instrumentation was performed during isoflurane/oxygen-maintained anesthesia. Before initiation of the study, isoflurane was allowed to reach end-tidal concentration < or = 0.5%, when baseline measurements were recorded. Medetomidine and atropine (0.044 mg/kg) were given IM after recording of baseline values. Ten minutes later, the loading dose of etomidate was given IM, and constant infusion was begun and continued for 60 minutes. Oxygen was administered via endotracheal tube throughout the study. Analgesia was evaluated by use of the standard tail clamp technique and a direct-current nerve stimulator. Sinoatrial and atrial-ventricular blocks occurred in 4 of 6 dogs within 2 minutes after administration of a medetomidine-atropine combination, but disappeared within 8 minutes. Apnea did not occur after administration of the etomidate loading dose. Analgesia was complete and consistent throughout 60 minutes of etomidate infusion. Medetomidine significantly (P < 0.05) increased systemic vascular resistance and decreased cardiac output. Etomidate infusion caused a decrease in respiratory function, but minimal changes in hemodynamic values. Time from termination of etomidate infusion to extubation, sternal recumbency, standing normally, and walking normally were 17.3 +/- 9.4, 43.8 +/- 14.2, 53.7 +/- 11.9, and 61.0 +/- 10.9 minutes, respectively. All recoveries were smooth and unremarkable. We concluded that this anesthetic drug combination, at the dosages used, is a safe technique in healthy Beagles.
Asunto(s)
Anestesia/veterinaria , Perros/fisiología , Etomidato/administración & dosificación , Hemodinámica/efectos de los fármacos , Imidazoles/administración & dosificación , Agonistas alfa-Adrenérgicos/administración & dosificación , Animales , Atropina/administración & dosificación , Combinación de Medicamentos , Femenino , Infusiones Intravenosas , Masculino , Medetomidina , Premedicación/veterinaria , Respiración/efectos de los fármacos , SeguridadRESUMEN
Hemodynamic and analgesic effects of medetomidine (30 micrograms/kg of body weight, IM), atropine (0.044 mg/kg, IM), and propofol (2 mg/kg, IV, as a bolus, and 165 micrograms/kg/min, IV, for 60 minutes, as an infusion) were evaluated in 6 healthy adult Beagles. Catheters were placed while the dogs were anesthetized with isoflurane in oxygen. Administration of isoflurane was then discontinued, and dogs were allowed to breath oxygen until end-tidal isoflurane concentration was < or = 0.5%. At this time, baseline measurements were recorded and medetomidine and atropine were administered. Ten minutes later, the bolus of propofol was given and the infusion was begun. Analgesia was evaluated with a tail clamp test and by use of a direct-current nerve stimulator. Sinoatrial and atrioventricular blockade developed in all 6 dogs within 2 minutes of administration of medetomidine and atropine, but disappeared within 10 minutes. Apnea did not develop after administration of propofol. Analgesia was strong and consistent throughout the entire 60-minute period of propofol infusion. Medetomidine significantly (P < 0.05) increased systemic vascular resistance and decreased cardiac output, compared with baseline values. Propofol infusion appeared to alleviate medetomidine-induced vasoconstriction. Recovery was smooth and uncomplicated. All dogs were able to walk normally at a mean time (+/- SEM) of 88.2 +/- 20.6 minutes after termination of propofol infusion. It was concluded that medetomidine, atropine, and propofol, as given in the present study, is a safe combination of anesthetic drugs for use in healthy Beagles.
Asunto(s)
Analgésicos/farmacología , Hemodinámica/efectos de los fármacos , Imidazoles/farmacología , Propofol/farmacología , Analgésicos/administración & dosificación , Animales , Atropina/farmacología , Presión Sanguínea/efectos de los fármacos , Temperatura Corporal/efectos de los fármacos , Dióxido de Carbono/sangre , Gasto Cardíaco/efectos de los fármacos , Perros , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Infusiones Intravenosas , Inyecciones Intravenosas , Masculino , Medetomidina , Oxígeno/sangre , Presión Parcial , Premedicación , Propofol/administración & dosificación , Arteria Pulmonar/efectos de los fármacos , Arteria Pulmonar/fisiología , Circulación Pulmonar/efectos de los fármacos , Respiración/efectos de los fármacosRESUMEN
The arrhythmogenic effects of anesthetic drugs are assessed using the arrhythmogenic dose of epinephrine (ADE) model. The purpose of this study was to determine the influence of cholinergic blockade (CB) produced by glycopyrrolate (G) on ADE in 1.5 minimum alveolar concentration (MAC) halothane (H)- and isoflurane (I)-anesthetized dogs. Eight dogs (weighing between 12.5 and 21.5 kg) were randomly assigned to four treatment groups (H, HG, I, and IG) and each treatment was replicated three times. Anesthesia was induced and maintained with H (1.31%, end-tidal [ET]) or I (1.95%, ET) in oxygen. Ventilation was controlled (carbon dioxide [PCO2] 35 to 40 mmHg, ET). G was administered 10 minutes before ADE determination at a dose of 22 microgram/kg (11 microgram/kg, intravenous [IV] and 11 micrograms/kg, intramuscular [IM]). The ADE was determined by IV infusion of epinephrine at sequentially increasing rates of 1.0, 2.5, and 5.0 micrograms/kg/min; and defined as the total dose of epinephrine producing at least four ectopic ventricular contractions (EVCs) within 15 seconds during a 3-minute infusion and up to 1 minute after the end of the infusion. Total dose was calculated as the product of infusion rate and time to arrhythmia. Data were analyzed using a randomized complete block analysis of variance. When significant (P < .05) F values were found a least significant difference test was used to compare group means. Values are reported as means +/- standard error. The ADE (micrograms/kg) for H, HG, I, and IG were 1.53 +/- 0.08, 3.37 +/- 0.46, 1.61 +/- 0.21, and > 15.00, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Arritmias Cardíacas/veterinaria , Enfermedades de los Perros/etiología , Glicopirrolato/uso terapéutico , Halotano/efectos adversos , Isoflurano/efectos adversos , Análisis de Varianza , Anestesia/veterinaria , Animales , Arritmias Cardíacas/inducido químicamente , Arritmias Cardíacas/etiología , Presión Sanguínea , Enfermedades de los Perros/inducido químicamente , Perros , Electrocardiografía/veterinaria , Epinefrina , Femenino , Frecuencia Cardíaca , MasculinoRESUMEN
In 4 mares suffering from dystocia, general anesthesia was induced with xylazine (1.1 mg/kg, IV) and ketamine (2.2 mg/kg, IV) and maintained with continuous intravenous infusion of ketamine (2 mg/ml), xylazine (0.5 mg/ml) and guaifenesin (50 mg/ml) in 1 L of 5% dextrose. The duration of the procedure of these mares were 40, 45, 180, and 35 minutes, respectively. For procedures required more than 1 hour (Mare 3), the dose of ketamine and xylazine in the mixture was reduced to 1 mg/ml and 0.25 mg/ml, respectively. Average infusion rate of the mixture used to maintain anesthesia for each mare was 2.5, 2.67, 2.28, and 2.21 ml/kg/hr. Recovery to standing occurred at 55, 75, and 180 minutes after termination of infusion for mares 1, 2, and 3, respectively. Xylazine reversal agent, tolazoline (2.2 mg/kg), was given to mare 1 to hasten the recovery; the mare stood within 30 minutes after tolazoline administration. Continuous infusion of guaifenesin-ketamine-xylazine can be an alternative anesthetic technique for prolonged obstetrical procedures under field conditions when suitable anesthetic equipment is not available. If recovery to standing is extended over 30 to 40 minutes, yohimbine or tolazoline can be administered to hasten recovery.